Till branscher

Hälsovård

Avgörande vägledning på din resa

Hälsovårdssektorn går framåt med stora kliv tack vare ny och banbrytande teknologi. I en bransch som präglas av reglering är det ofta strategiska partnerskap som är nyckeln till framgångsrik företagsutveckling inom hälsovårdssektorn.

Våra passionerade rådgivare, som backas upp globalt av specialiserade team, använder sin djupa sektorexpertis för att hjälpa dig hitta en konkurrensfördel, hantera lokal marknadsdynamik och forma den lämpligaste strategin.

Kontakta rådgivare
VÄRLDEN ÖVER
457
slutförda affärer inom Hälsovård
VÄRLDEN ÖVER
Utforska alla våra branschrelaterade affärer
Gå till Affärer
Kungshusen Medicinska has been acquired by Diploma
Hälsovård

Kungshusen Medicinska has been acquired by Diploma

Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.

Lär dig mer
MediCA group has been acquired by Repharm
Hälsovård

MediCA group has been acquired by Repharm

CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.

Lär dig mer
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Riskkapital | Hälsovård

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Lär dig mer
“It was particularly pleasing to see the level of support received for this financing, reinforcing confidence in SNG001, our wholly-owned drug and potential breakthrough treatment for COVID-19 patients. Oaklins’ team has always been supportive and built a good register of institutions in March which was broadened further in this funding. It was a very successful fundraising and the level of demand was such that we were comfortably able to increase the size of the funding. Having demonstrated the great promise of SNG001 in hospitalized COVID-19 patients earlier this year, we now have the resources to be able to rapidly progress this potential breakthrough treatment in such a critical area of unmet need.”

Richard Marsden

CEO, Synairgen plc

 Read more 
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=FI&includes=featured_images,tags&language=sv&limit=1&tags=healthcare

Quarterly Highlights | Q2 2022

Although challenges and risk factors such as global inflation and geopolitics have impacted M&A activity this year, many of the elements that encouraged the M&A boom of 2021 are still playing a key role in transactions. Indeed, this could even turn out to be a time of opportunities.

Lär dig mer

Prata med våra lokala rådgivare

Marcus Blomqvist

Marcus Blomqvist

Partner
Helsingfors, Finland
Oaklins Finland
Se profil Kontakta oss

Träffa våra globala specialister

Robert Boersma

Robert Boersma

Partner
Amsterdam, Nederländerna
Oaklins Netherlands
Se profil Kontakta oss
Dino Theodorou

Dino Theodorou

Director
Johannesburg, Sydafrika
Oaklins Grindrod
Se profil Kontakta oss
Stuart Goodman

Stuart Goodman

Director
London, Storbritannien
Oaklins Evelyn Partners
Se profil Kontakta oss
Michael Jewell

Michael Jewell

Partner
London, Storbritannien
Oaklins Cavendish
Se profil Kontakta oss
Michael S. Goldman

Michael S. Goldman

Managing Director
New York, USA
Oaklins TM Capital
Se profil Kontakta oss